EXKA is a cannabinoid manufacturing and innovation company specializing in pharmaceutical-grade extracts, active pharmaceutical ingredients (APIs), and medical formulations for regulated global markets. Operating from Canada under rigorous quality and compliance standards, EXKA supports licensed partners with reliable, scalable cannabinoid manufacturing designed to meet the expectations of medical and pharmaceutical environments. Our expertise spans the full value chain — from plant science and genetics to advanced extraction, purification, and formulation — enabling consistent product performance and batch reproducibility. We collaborate with international partners seeking dependable cannabinoid supply and differentiated medical formats, including oils, oral sprays, and customized formulations adapted to evolving regulatory frameworks. Core capabilities : • GMP-aligned cannabinoid extraction and purification • Active pharmaceutical ingredient (API) manufacturing • Medical oil and oral spray formulation • Contract development and manufacturing (CDMO) • Quality systems focused on consistency, traceability, and compliance EXKA’s multidisciplinary scientific and operational team combines pharmaceutical, biotechnology, and cannabis industry expertise to deliver manufacturing solutions that reduce risk and accelerate product deployment in regulated markets. 🌍 Partnering internationally across medical cannabis jurisdictions.
Looking for a particular EXKA Inc. employee's phone or email?
Maxime Paris is the President of EXKA Inc..
17 people are employed at EXKA Inc..
EXKA Inc. is based in Mirabel, Quebec.
The NAICS codes for EXKA Inc. are [541, 54, 541713, 5417, 54171].
The SIC codes for EXKA Inc. are [87, 873].